Hot Off the Press Enduring Module
Course ID: 22CE00077

Management of Anti-Obesity Medications
Sheri Thomas, DO
Speakers Bureau: Nova Nordisk & Rhythm Pharmaceuticals

1. Discuss the pharmacotherapeutics of anti-obesity medications in primary care and the expectations surrounding patient goals.
2. Articulate the contraindications and side effects when considering medical management of obesity.
3. Describe current FDA approved anti-obesity medications including appropriate dosage and long-term management as derived from case-based approaches.

Heart Failure Management in 2022
Teri Diedrich, APRN-NP, CHFN, FHFSA
Nothing to disclose

1. Discuss medication initiation and titration for heart failure based on the 2022 heart failure guidelines
2. Identify medication side effects in the treatment of heart failure
3. Describe patient populations eligible for new heart failure pharmaceuticals

Update on Immune Checkpoint Inhibitors & Clinical Pearls for Non-Oncology Providers
Lauren Bodhaine-Haywood, PharmD, BCOP, BCPS
Off-Label Disclosure: Prednisone/methylprednisolone: Treatment of immune-related toxicities per NCCN

1. Review the growing role of immune checkpoint inhibitors (ICI’s) in the treatment of patients with cancer
2. Identify best practices for managing adverse effects associated with ICI-targeted therapy
3. Demonstrate prompt recognition of symptoms and early intervention for less common immune-related adverse events
4. Discuss the importance of a multidisciplinary approach to improve the collaborative performance of the interprofessional care team in the medical management of patients with cancer

Accreditation

				In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The University of Nebraska Medical Center designates this activity for 3.0 ANCC contact hours. 3.0 contact hours are related to pharmacotherapeutic content.
				University of Nebraska Medical Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.